http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109793811-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-481 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08 |
| filingDate | 2019-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109793811-B |
| titleOfInvention | Ganoderma preparation with effects of inhibiting prostatic hyperplasia, protecting liver and enhancing immunity |
| abstract | The invention discloses a ganoderma lucidum preparation with triple effects of inhibiting prostatic hyperplasia, protecting liver and improving immunity, which comprises, by mass, 2.5-3.5% of ganoderma lucidum polysaccharide, 1.8-2.4% of astragalus polysaccharide, 0.0008-0.0012% of ganoderic acid A, 0.0004-0.0006% of ganoderic acid G, 0.0004-0.0006% of ganoderic acid D, 0.0007-0.0009% of ganoderic ketone triol and 0.0004-0.0006% of ganoderic acid DM. On the basis of inhibiting prostatic hyperplasia and protecting liver, the ganoderma lucidum preparation is compatible with astragalus root, the effects of inhibiting prostatic hyperplasia, protecting and nourishing liver and improving immunity of various medicinal materials are synergistically exerted, and the obtained ganoderma lucidum tablets can inhibit prostatic hyperplasia, improve chronic hepatitis and effectively prevent relapse and deterioration of diseases. |
| priorityDate | 2019-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.